Similar to the above results from the network pharmacology analysis, stigmasterol showed high binding energy with PI3KR1, suggesting that CLM alleviates depression via modulation of the PI3K/Akt signaling pathway. The gene discussed is AKT1; the disease is depressive symptom measurement.